1.
Oliveira GLA de, Almeida AM, Silva AL da, et al. Incorporated antivirals for chronic hepatitis B in Brazil: a cost-effectiveness analysis. Rev. saúde pública. 2013;47(4):769-780. doi:10.1590/rsp.v47i4.76609